氨基酸及其衍生物

Search documents
华恒生物股价小幅回落 独立董事任期届满离任
Jin Rong Jie· 2025-08-11 18:47
Group 1 - The core viewpoint of the article highlights the recent performance and developments of Huaheng Biological, including stock price changes and significant announcements [1] - On August 11, Huaheng Biological's stock closed at 37.37 yuan, down 0.82% from the previous trading day, with a trading volume of 1.56 billion yuan and a turnover rate of 1.67%, resulting in a total market capitalization of 9.347 billion yuan [1] - The company specializes in the research, production, and sales of amino acids and their derivatives, with applications in food, pharmaceuticals, and feed industries, and is involved in the chemical products sector, including synthetic biology and vitamins [1] Group 2 - On August 11, Huaheng Biological announced that independent director Zhang Qifeng applied for resignation after serving for six consecutive years, and will no longer hold any position in the company, as per relevant regulations requiring the replacement of independent directors upon term expiration [1] - In terms of capital flow, on August 11, there was a net outflow of 10.9682 million yuan from main funds, accounting for 0.12% of the circulating market value, while over the past five days, there was a net inflow of 68.9725 million yuan, representing 0.74% of the circulating market value [1]
华恒生物股价下跌2.14% 公司筹划H股上市事宜
Jin Rong Jie· 2025-07-30 20:35
Group 1 - As of July 30, 2025, Huaheng Biological's stock price is 33.77 yuan, down 0.74 yuan or 2.14% from the previous trading day [1] - The trading volume on the same day was 54,947 hands, with a transaction amount of 188 million yuan [1] - Huaheng Biological operates in the chemical products industry, focusing on the research, production, and sales of amino acids and their derivatives, which are widely used in food, pharmaceuticals, and feed sectors [1] Group 2 - The company is planning to issue overseas shares and list on the Hong Kong Stock Exchange, with details yet to be determined [1] - This issuance will not change the company's controlling shareholder or actual controller [1] - As of July 30, 2025, the net outflow of main funds for Huaheng Biological was 6.0878 million yuan, accounting for 0.07% of the circulating market value [1]